Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA Polymerase III is the primary enzyme responsible for DNA replication in bacteria. It catalyzes the addition of deoxyribonucleotides to a growing DNA strand in the 5' to 3' direction, using an existing strand as a template. While not directly targeted by metronidazole, its function is inhibited by the DNA damage caused by the reduced form of the drug. Metronidazole is a prodrug that becomes activated under anaerobic conditions, forming nitroso radicals that disrupt bacterial DNA, leading to cell death.
Metronidazole is converted to a nitroso radical that damages bacterial DNA, inhibiting DNA synthesis and leading to cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA Polymerase III (None).